Life Sciences BREXIT Countdown

We have been examining the potential consequences of BREXIT for the pharmaceutical and medical device industries since before the results of the referendum were known. We are working with our clients and experts in other fields to provide a global view of the risks and opportunities that Brexit will present.

Hogan Lovells is organizing this webinar to provide pharmaceutical and medical device companies with a detailed update on recent developments and a guide to the potential issues that may arise in the five months leading up to the UK's exit on 29 March 2019.

Join us on 6 November 2018, for a complimentary webinar where we will discuss the major issues to be addressed, what this means for your business and how we can help you prepare.

Topics will include:   

  • Will it be necessary to relabel UK medicinal products and medical devices before introducing these onto the EU market?
  • What do we do about batch release?
  • Is stockpiling the answer?
  • What is the position of UK notified bodies?

Back To Listing
Loading data